We are live on
!
Find out more
DLA
Douglas Lane & Associates Portfolio holdings
AUM
$7.37B
1-Year Est. Return
21.9%
This Fund
S&P 500
This Quarter
Est. Return
-2.46%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.96B
AUM Growth
-$234M
(-3.8%)
Cap. Flow
-$704K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
20.98%
Holding
251
New
12
Increased
75
Reduced
130
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$12.3M |
| 2 |
Lamb Weston
LW
|
+$11.1M |
| 3 |
RXO
RXO
|
+$10.9M |
| 4 |
Moderna
MRNA
|
+$10.6M |
| 5 |
Elanco Animal Health
ELAN
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$29.3M |
| 2 |
XPO
XPO
|
+$15.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$8.2M |
| 4 |
Microsoft
MSFT
|
+$7.76M |
| 5 |
GE Aerospace
GE
|
+$6.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.86% |
| 2 | Healthcare | 15.7% |
| 3 | Technology | 15.69% |
| 4 | Industrials | 10.96% |
| 5 | Communication Services | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Geron
GERN
$962M
| $150K | ﹤0.01% |
70,900
-5,000
| -7% | -$13.6K |
|
227
Star Holdings Shares of Beneficial Interest
STHO
$115M
| $141K | ﹤0.01% |
11,269
-9,353
| -45% | -$130K |
|
228
Transact Technologies
TACT
$57.5M
| $77.6K | ﹤0.01% |
12,081
| – | – |
|
|
ALLK
229
DELISTED
Allakos
ALLK
| $22.8K | ﹤0.01% |
+10,051
| New | +$37.3K |
|
230
Heron Therapeutics
HRTX
$71.3M
| $10.3K | ﹤0.01% |
10,000
| – | – |
|
|
ADAP
231
DELISTED
Adaptimmune Therapeutics
ADAP
| $8.58K | ﹤0.01% |
11,000
-2,000
| -15% | -$1.68K |
|
|
LQMT
232
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
| $410 | ﹤0.01% |
10,000
| – | – |
|
233
AGNC Investment
AGNC
$12.8B
| – | – |
-12,600
| Closed | -$128K |
|
234
Bath & Body Works
BBWI
$3.94B
| – | – |
-5,925
| Closed | -$222K |
|
235
Brown-Forman Class B
BF.B
$12.9B
| – | – |
-3,345
| Closed | -$223K |
|
236
Copart
CPRT
$27.2B
| – | – |
-4,520
| Closed | -$206K |
|
237
Kinder Morgan
KMI
$69.2B
| – | – |
-12,036
| Closed | -$207K |
|
238
Landstar System
LSTR
$6.15B
| – | – |
-1,039
| Closed | -$200K |
|
239
Masco
MAS
$14.9B
| – | – |
-4,006
| Closed | -$230K |
|
240
Sony
SONY
$139B
| – | – |
-12,060
| Closed | -$217K |
|
|
FRC
241
DELISTED
First Republic Bank
FRC
| – | – |
-316,956
| Closed | -$174K |
|
|
SIVB
242
DELISTED
SVB Financial Group
SIVB
| – | – |
-80,917
| Closed | -$41.9K |
|
Similar funds
GJL
DKCM
KWM
GLF
JF
YAM
ASN
DS
Douglas Lane & Associates's Q3 2023 Portfolio in Review
As of Q3 2023, Douglas Lane & Associates held 251 positions worth $5.96B, down 3.8% from $6.19B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Douglas Lane & Associates's Q3 2023 filing shows 12 new, 75 increased, 130 reduced and 13 closed positions. Its largest new stake was Kenvue: 61,993 shares worth $1.24M. The largest sale was NVIDIA, an estimated $29.3M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
- Douglas Lane & Associates's largest Q3 2023 buy was Kenvue: 61,993 shares worth $1.24M.
- Douglas Lane & Associates added most to International Flavors & Fragrances in Q3 2023, an estimated $12.3M increase.
- Douglas Lane & Associates's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $29.3M.
- Douglas Lane & Associates fully exited Masco in Q3 2023, selling an estimated $230K.
- Douglas Lane & Associates's ten largest holdings make up 21% of its $5.96B portfolio in Q3 2023.
- Douglas Lane & Associates opened 12 new positions and closed 13 in Q3 2023.
- Douglas Lane & Associates's portfolio value fell 3.8% quarter-over-quarter to $5.96B.
Based on Douglas Lane & Associates's 13F filing for Q3 2023, filed 16 Oct 2023.